|
| Chapter 1 Parkinson's Disease: Early Diagnosis Last Updated: February 18, 2013 |
| Chapter 2 Clinical Trial Design in Parkinson's Disease Last Updated: February 18, 2013 |
| Chapter 3 MAO-B Inhibitors in Parkinson's Disease: Evaluating the Evidence for Neuroprotection Last Updated: February 18, 2013 |
| Chapter 4 Management of Early-Stage Parkinson’s Disease Last Updated: February 18, 2013 |
| Chapter 5 Management of Moderate- to Advanced-Stage Parkinson’s Disease Last Updated: February 18, 2013 |
| Chapter 6 Management of Nonmotor Symptoms of Parkinson’s Disease Last Updated: February 18, 2013 |
| Chapter 7 Impulse Control and Related Disorders in Parkinson’s Disease Last Updated: February 18, 2013 |
| Chapter 8 Neuroimaging in Parkinson’s Disease Last Updated: February 18, 2013 |
| Chapter 9 Neuroimaging in Early Parkinson’s Disease: Role and Appropriate Use |
|
|
|
||||||||||
| Chapter 2 – Clinical Trial Design in Parkinson's Disease | ||||||||||
|
||||||||||
|
Activity Goal The goal of this CME/CE activity is to examine preclinical nonmotor features, disease modification trials, clinical disease progression, MAO-B inhibitors, and current strategies for treating and managing patients with Parkinson's disease. |
||||||||||
|
Target Audience This CME/CE activity is designed for Parkinson’s disease physician specialists, community neurologists, Parkinson’s disease nurse specialists, and pharmacists. |
||||||||||
Learning Objectives
|
||||||||||
| top |
||||||||||
|
CME Information: Physicians
Statement of Accreditation Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Projects In Knowledge® designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CE Information: Nurses Projects In Knowledge® (PIK) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Projects In Knowledge is also an approved provider by the California Board of Registered Nursing, Provider Number CEP-15227. Upon completion of this course, participants will be awarded 1.11 nursing contact hour(s). DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN, or PIK endorsement of any commercial product or service.
CE Information: Pharmacists  Projects In Knowledge® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This chapter is worth up to 2.00 contact hours (0.2 CEUs). The ACPE Universal Activity Number assigned to this Application-type activity is 0052-0000-12-1735-H01-P. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. top |
||||||||||
|
Disclosure Information The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR). Robert A. Hauser, MD, MBA, has received honoraria from Allergan Neuroscience, Biogen Idec, Boehringer Ingelheim, Embryon, GE Healthcare, Genzyme, GlaxoSmithKline, Impax, Ipsen Pharmaceuticals, Kyowa Pharmaceutical, Merck Serono international, Novartis Pharmaceuticals Corporation, Quintiles, Santhera, Schering Plough, Solvay Pharmaceuticals, Synosia Therapeutics, Teva Neurosciences, UCB, and Xenoport. Lauren A. Cerruto (medical writer), has no significant relationships to disclose. Peer Reviewer has disclosed no significant relationships. Dorothy Caputo, MA, BSN, RN (lead nurse planner) has no significant relationships to disclose. Bernadette Marie Makar, MSN, NP-C, APRN-C (nurse planner) has no significant relationships to disclose. Projects In Knowledge’s staff members have no significant relationships to disclose. top |
||||||||||
Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process. The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge. This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
|
||||||||||
|
|
||||||||||
|
|
|
|
|
These independent CME/CE activities are supported by an educational grant from Teva Neuroscience.
|
|
|
Release Date: July 30, 2012. Termination Date: July 29, 2013. |
|
Estimated time for completion of this activity: CME: 2.00 hours CNE: 1.11 hours CPE: 2.00 hours |
|
CME/CE Instructions To obtain CME/CE credit for this activity:
There is no fee for this activity. |
|
| For questions about content or obtaining CME credit, please contact us. | |
